ロード中...
Genetically modified human placenta-derived mesenchymal stem cells with FGF-2 and PDGF-BB enhance neovascularization in a model of hindlimb ischemia
Ischemic diseases represent a challenging worldwide health burden. The current study investigated the therapeutic potential of genetically modified human placenta-derived mesenchymal stem cells (hPDMSCs) with basic fibroblast growth factor (FGF2) and platelet-derived growth factor-BB (PDGF-BB) genes...
保存先:
| 出版年: | Mol Med Rep |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4581748/ https://ncbi.nlm.nih.gov/pubmed/26239842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.4089 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|